Reduction of body weight, liver steatosis and expression of stearoyl‐CoA desaturase 1 by the isoflavone daidzein in diet‐induced obesity
Ana Crespillo, FR de Fonseca(Instituto de Salud Carlos III), Juan Suárez(Hospital Regional Universitario de Málaga), Ana Martı́nez(Consejo Superior de Investigaciones Científicas), Vidal Perez‐Valero(Hospital Doctor José Molina Orosa), Margarita Vida(Instituto de Investigación Biomédica de Málaga), Pedro Fernández‐Llebrez(Universidad de Málaga), M. Carmen Alonso(Gobierno de Aragón), Patricia Rivera(Instituto de Investigación Biomédica de Málaga), Francisco Javier Pavón(Gobierno de Aragón), Silvana‐Yanina Romero‐Zerbo(Instituto de Investigación Biomédica de Málaga), FJ Bermúdez‐Silva(Instituto de Salud Carlos III), Antonia Serrano(Hospital Regional Universitario de Málaga)
Cited by 99
Related Papers
COVID-19: Drug Targets and Potential Treatments
|Journal of Medicinal Chemistry|2020|469
First Non-ATP Competitive Glycogen Synthase Kinase 3 β (GSK-3β) Inhibitors: Thiadiazolidinones (TDZD) as Potential Drugs for the Treatment of Alzheimer's Disease
|Journal of Medicinal Chemistry|2002|448
GSK-3 Inhibitors: Preclinical and Clinical Focus on CNS
|Frontiers in Molecular Neuroscience|2011|348
Glycogen synthase kinase 3 (GSK‐3) inhibitors as new promising drugs for diabetes, neurodegeneration, cancer, and inflammation
|Medicinal Research Reviews|2002|334
TNFα disrupts blood brain barrier integrity to maintain prolonged depressive-like behavior in mice
|Brain Behavior and Immunity|2018|293